Introduction
Body iron supply is provided both by iron recycling from senescent erythrocytes within the reticuloendothelial system and dietary iron absorption by duodenal enterocytes . The liver-iron regulatory hormone, hepcidin, controls these two iron-delivery pathways via its [1 ] targeted degradation of the cell surface iron exporter, ferroportin. As a consequence, iron availability in the circulation is decreased, leading to hypoferraemia , . Neither the lack of hepcidin nor its excess can be compensated for by the body, the results of which [2 3 ] ultimately manifest in either iron overload or iron deficiency anemia, respectively.
Hepcidin gene expression is tightly regulated by body iron status and is dependent upon bone morphogenetic protein 6 (Bmp6) and hemojuvelin (Hjv). Binding of the iron-regulated Bmp6 ligand to its receptors activates a signaling cascade leading to hepcidin [4 ] transcription via phosphorylation of son of mother against decapentaplegic (Smad) 1/5/8 effectors . Hjv, a GPI-linked membrane protein [5 ] synthesized by the hepatocytes, is a Bmp6 coreceptor . The critical role of the Bmp6/Hjv/Smad pathway in iron homeostasis is [5 ] supported by the loss of hepcidin expression and massive parenchymal iron overload observed in and mice as well as in Bmp6 / − − Hjv / − − mice with targeted liver deletion of Smad4 . [6 -9 ] Recently, the serine protease matriptase-2 (also known as TMPRSS6) has been connected to this iron-pathway due to its [10 -12 ] proteolysis of Hjv . Matriptase-2 is a type II serine protease that is predominately expressed in the liver (for review ). Matriptase-2
[13 ] [14 ] deficient mice , have very high levels of hepcidin, which lead to the inhibition of dietary iron absorption and cause a severe iron [10 12 ] deficiency anemia phenotype. Matriptase-2 was thus characterized as a negative regulator of hepcidin gene expression. Accordingly, Du et al. demonstrated that overexpression of normal matriptase-2 protein in hepatoma cells suppresses the activation of hepcidin expression [10 ] . The anemic phenotype of matriptase-2 deficient mice is mirrored in patients with matriptase-2 mutations who present with iron-refractory iron deficiency anemia (IRIDA) . Indeed, IRIDA patients show inappropriately high hepcidin levels , , , which explain lack of [11 ] [11 14 15 ] dietary iron absorption and partial response to parenteral iron treatment . [16 ] The goal of this study was to characterize the relationship between matriptase-2 and the iron-regulated ligand of Hjv, Bmp6, by in vivo analyzing the role of Bmp6 in the setting of anemia in mice deficient for matriptase-2. Towards this purpose, we intercrossed matriptase-2 and Bmp6-deficient mice and compared the iron status of the double mutant mice with that of wild-type controls or single mutant mice. 2 6 mice on a mixed 129/Ola x C57BL/6 background were mated to mice on an outbred CD1 background Tmprss6 tm1Otin [12 ] Bmp6 tm1Rob
[ . F1 mice, heterozygous for both the (hereafter referred to as ) and the alleles (referred to as
) were then intercrossed and the F2 progeny genotyped as previously described , . As expected, the nine possible genotypic Bmp6 + / − [6 12 ] combinations were observed among the F2 mice.
Mice were cared for in accordance with the European convention for the protection of laboratory animals . Animals were given free « » access to tap water and standard laboratory mouse chow diet (AO3, iron content 280 mg/kg, UAR, France). Mice used in this study were 8 to 13-week-old females and had a mixed 129/Ola C57BL/6 CD1 background. Hematological parameters as well as plasma and liver × × iron were obtained as previously described .
[17 ]
RNA extraction and real-time quantification of the hepcidin and actin transcripts were performed as reported in . Standardized β [18 ] genetic nomenclature for mouse hepcidin is Hamp and Atcb for actin.
β Student tests were used to compare quantitative traits between mouse groups. values less than .05 were considered as statistically t P significant.
Results and discussion
To investigate the role of Bmp6 in the pathogenesis of iron-refractory iron deficiency anemia, we intercrossed matriptase-2 and Bmp6-deficient mice and analyzed iron metabolism in their F2 progeny.
As recently published , , liver hepcidin expression was repressed in mice compared with controls ( ), [6 7 ] Bmp6 mice were anemic and presented with significantly decreased Hb levels, as well as RBC, Hct and MCV ( ). In addition, as Table 1 previously reported , they exhibited lower gene expression than wild-type controls (data not shown). systemic iron homeostasis by decreasing hepcidin gene expression and increasing plasma and liver iron ( ). Fig. 1 Although hematological parameters were found to be normal in mice deficient for both Hjv and matriptase-2 , , supporting the [19 20 ] role of matriptase-2 as a regulator of Hjv expression at the hepatocyte membrane, the role of Bmp6 in this process was not clearly defined.
The data obtained in this study indicate that hepcidin overexpression which results from matriptase-2 inactivation requires the presence of Bmp6. Indeed, neither the activation of the Hjv/Smad signaling pathway nor the establishment of the anemic phenotype were observed in double knockout mice. 3 6 In conclusion, the present data further support that Bmp6 is the physiological ligand of Hjv and demonstrate that the regulation of Hjv membrane expression by matriptase-2 serves to tightly control the signaling pathway induced by Bmp6.
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